BSX : Post-market Study Data Reinforce Success & Safety Of ACURATE Neo2 Aortic Valve System

(RTTNews) - Boston Scientific Corp. (BSX) said that post-market study data reinforced clinical procedural success and safety of the ACURATE neo2 Aortic Valve System.

The ACURATE neo2 Post Market Clinical Follow-up (PMCF) study evaluated the performance of the ACURATE neo2TM Aortic Valve System. The findings showed a high procedural success......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - Monday, 28 November
Share |